<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) June 14, 2000
APPLIED ANALYTICAL INDUSTRIES, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware 0-21185 04-2687849
--------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission File Number) (I.R.S. Employer
of Incorporation) Identification No.)
2320 Scientific Park Drive
Wilmington, North Carolina 28405
----------------------------------------
(Address of Principal Executive Offices)
(Zip Code)
(910) 254-7000
-----------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
Not Applicable
-----------------------------------------------------
(Former name or address, if changed from last report)
<PAGE> 2
Item 5. Other Events.
On June 14, 2000, Applied Analytical Industries, Inc. (the "Company")
issued a press release (the "Release") concerning comments the Company's Chief
Executive Officer made at the Goldman Sachs Healthcare Conference. The Release
is filed as Exhibit 99.1 hereto and is incorporated by reference herein.
Item 7. Financial Statements and Exhibits.
(a) Exhibits
Exhibit 99.1 -- Press release dated June 14, 2000
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: June 16, 2000
APPLIED ANALYTICAL INDUSTRIES, INC.
By:
William L. Ginna, Jr.
Executive Vice President and Chief
Financial Officer
3
<PAGE> 4
EXHIBIT INDEX
Exhibit No. Exhibit
----------- -------
Exhibit 99.1 -- Press release dated June 14, 2000
4
